NO20035043D0 - Fremgangsmåte for behandling av okular hypertensjon og glaukom - Google Patents

Fremgangsmåte for behandling av okular hypertensjon og glaukom

Info

Publication number
NO20035043D0
NO20035043D0 NO20035043A NO20035043A NO20035043D0 NO 20035043 D0 NO20035043 D0 NO 20035043D0 NO 20035043 A NO20035043 A NO 20035043A NO 20035043 A NO20035043 A NO 20035043A NO 20035043 D0 NO20035043 D0 NO 20035043D0
Authority
NO
Norway
Prior art keywords
glaucoma
procedure
treatment
ocular hypertension
ocular
Prior art date
Application number
NO20035043A
Other languages
English (en)
Norwegian (no)
Inventor
Ryuji Ueno
Original Assignee
Sucampo Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sucampo Ag filed Critical Sucampo Ag
Publication of NO20035043D0 publication Critical patent/NO20035043D0/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20035043A 2001-05-14 2003-11-13 Fremgangsmåte for behandling av okular hypertensjon og glaukom NO20035043D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29035501P 2001-05-14 2001-05-14
PCT/JP2002/004600 WO2002092098A1 (en) 2001-05-14 2002-05-13 Method for treating ocular hypertension and glaucoma

Publications (1)

Publication Number Publication Date
NO20035043D0 true NO20035043D0 (no) 2003-11-13

Family

ID=23115609

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20035043A NO20035043D0 (no) 2001-05-14 2003-11-13 Fremgangsmåte for behandling av okular hypertensjon og glaukom

Country Status (10)

Country Link
US (1) US20050014837A1 (https=)
EP (1) EP1390035A1 (https=)
JP (1) JP2004529177A (https=)
KR (1) KR20040008174A (https=)
CN (1) CN1525861A (https=)
BR (1) BR0209601A (https=)
CA (1) CA2444627A1 (https=)
MX (1) MXPA03010363A (https=)
NO (1) NO20035043D0 (https=)
WO (1) WO2002092098A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003215820A1 (en) * 2002-03-28 2003-10-13 Sucampo Ag Method for treating ocular hypertension and glaucoma
US8580851B2 (en) 2002-08-21 2013-11-12 Sucampo Ag Ophthalmic solution
WO2005018646A1 (ja) * 2003-08-21 2005-03-03 Sucampo Ag 眼科用組成物
AR043161A1 (es) * 2003-02-14 2005-07-20 Sucampo Pharmaceuticals Inc Composicion oftalmica para tratar hipertension ocular y glaucoma
US12478503B2 (en) 2009-05-18 2025-11-25 Glaukos Corporation Implants with controlled drug delivery features and methods of using same
US10206813B2 (en) 2009-05-18 2019-02-19 Dose Medical Corporation Implants with controlled drug delivery features and methods of using same
US9061034B2 (en) 2010-07-29 2015-06-23 Allergan, Inc. Preservative free bimatoprost and timolol solutions
US9078854B2 (en) 2010-07-29 2015-07-14 Allergan, Inc. Preservative free bimatoprost and timolol solutions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5212200A (en) * 1987-09-18 1993-05-18 R-Tech Ueno, Ltd. Ocular hypotensive agents
US5208256A (en) * 1990-05-22 1993-05-04 R-Tech Ueno, Ltd. Treatment of ocular hypertension with a synergistic combination for ocular administration
DE69232150T2 (de) * 1992-03-19 2002-03-07 R-Tech Ueno, Ltd. Behandlung von Augenhochdruck mit Betablockern und Prostansäurederivaten
TW420611B (en) * 1995-03-10 2001-02-01 R Tech Ueno Ltd Pharmaceutical composition containing prostanoic acid compounds for the treatment of optic nerve disorder
ATE289817T1 (de) * 1998-12-25 2005-03-15 Sucampo Ag Arzneimittelzusammenstellung zur behandlung des erhöhten augeninnendrucks oder des glaukom
US6458836B1 (en) * 2000-03-16 2002-10-01 Sucampo, A.G. Treatment of ocular hypertension and glaucoma

Also Published As

Publication number Publication date
EP1390035A1 (en) 2004-02-25
JP2004529177A (ja) 2004-09-24
WO2002092098A1 (en) 2002-11-21
KR20040008174A (ko) 2004-01-28
US20050014837A1 (en) 2005-01-20
BR0209601A (pt) 2004-03-23
CA2444627A1 (en) 2002-11-21
CN1525861A (zh) 2004-09-01
MXPA03010363A (es) 2004-03-16

Similar Documents

Publication Publication Date Title
IS7215A (is) Aðferðir til að meðhöndla nýæðarsjúkdóma í augum
PL366636A1 (en) Pyranoindazoles and their use for the treatment of glaucoma
GB2402674B (en) Compositions and methods for the treatment of glaucoma or ocular hypertension
AU2002340122A1 (en) Pathological tissue detection and treatment employing targeted benzoindole optical agents
EP1592435A4 (en) EYE FORMULATION FOR THE PREVENTION AND TREATMENT OF EYE DRESS
NO20041216L (no) Imidazol-4-karboksamidderivater, fremstilling og anvendelse derav for behandling av overvekt
NO20035609D0 (no) Fremgangsmåte for kontinuerlig naftabehandling
NO20026008L (no) Fremgangsmåte for behandling av cardiovaskul¶re sykdommer
HUP0401605A3 (en) Integrin inhibitors for the treatment of eye diseases
NO20052751D0 (no) Oftalmisk preparat for behandling av okulaer hypertensjon.
EP1392658A4 (en) NOVEL FUSED INDAZOLES AND INDOLES AND THEIR USE IN THE TREATMENT OF GLAUCOMES
NO20034123L (no) Fremgangsmåte for behandling av brennstoff
ATE443060T1 (de) Benzoägüchinolinderivate zur behandlung von glaucom und kurzsichtigkeit
DK1267847T3 (da) 5HT2-antagonist til regulering af IOP og behandling af glaucom
NO20035043D0 (no) Fremgangsmåte for behandling av okular hypertensjon og glaukom
EP1455780A4 (en) NEW BENZODIFURANIMIDAZOLIN AND BENZOFURANIMIDAZOLIN DERIVATIVES AND THEIR USE FOR THE TREATMENT OF GLAUCOMA
NO20031779D0 (no) Fremgangsmåte og preparat for behandling av okular hypertensjon og glaukom
NO20024381D0 (no) Behandling av okular hypertensjon og gluakom
DK1268482T3 (da) Pyranoindoler til behandling af glaukom
AR026062A1 (es) Tratamiento de desordenes oculares
NO20042476L (no) Anvendelse av desoxypeganin for behandling av klinisk depresjon
NO20025760L (no) S-metyl-dihydro-ziprasidon for behandling av psykiatriske og okkul¶re forstyrrelser
NO20035706D0 (no) Antihistaminer for behandling av nesetetthet og neseobstruksjon
HK1064946A (en) Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma
AU2002322769A1 (en) Method for treatment of ocular hypertension and glaucoma

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application